October 13, 2026

#vaccination — Tuesday, October 13, 2026 (2 items)

hot top new

0		ℹ	Second-season observations after prophylaxis in the evaluation of the impact of nirsevimab in Galicia (NIRSE-GAL) study: mechanistic interpretation and implications for respiratory syncytial virus prevention strategy. (doi.org)	Martinon-Torres F … Finn A Lancet Infectious Diseases 2026-10-13	#prophylaxis #rsv #vaccination #pediatrics #infection
0		ℹ	Immunogenicity and shedding of live-attenuated intranasal respiratory syncytial virus vaccine in children aged 6-18 months by baseline serostatus: a multicentre, randomised, placebo-controlled, phase 1/2 trial. (doi.org)	Idoko OT … Dhingra MS Lancet Microbe 2026-10-13	#vaccination #immunogenicity #rsv #pediatrics #serology